Pavel Printsev

Pavel Printsev serves as the Chief Business Development Officer at 3billion since August 2025, bringing extensive experience in the biotech and pharmaceutical sectors. Previous roles include Director of Business Development at Bridge Biotherapeutics, Inc., Member of the Selection Committee at BaseLaunch, Associate Director at NS Investment, Global Business Development Manager at Hugel Aesthetics, and Global Business Development Manager at Dong-A Pharmaceutical Co., Ltd. In earlier career stages, Pavel worked as a Research Scientist, contributing to drug discovery projects. Academic credentials include a Master of Science in Organic Chemistry from Seoul National University and a Bachelor of Science in Chemistry from the University of Toronto, complemented by an international research stint at the National University of Singapore.